← Leaderboards
William C. Lamanna
University Of California, San Diego
$114,125
Attributed
$114,125
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $53K · FY2010–12$100K$75K$50K$25K$0
'10
'11
'12
Funding mix
By agency
NIH$114,125 · 1
By mechanism
F32$114,125 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Richard L Gallo$35,320,517
- Philip Gordts$3,240,157
- Christina Sigurdson$15,317,187
- Stephanie Leal$123,412
- Matthew Shtrahman$4,240,747
Others in their field
Top investigators on “Metabolic Diseases”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,600,316
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$127,070,863
- Carol Nesel · Westat$116,355,411
Research focus
Metabolic DiseasesPathologyHeparitin SulfateMental RetardationNeuropathologyNew Therapeutic TargetGlycosaminoglycansHeparan Sulfate BiosynthesisInheritedLifeCatabolismMucopolysaccharidosesDermatan SulfateDermatan Sulfate Chondroitin SulfateDisease ModelCellsCell TypeEnzymesChondroitinFibroblastsGangliosidesBrainGeneticPharmacological Treatment
Grant awards (3)
Substrate Reduction Therapy Strategies for Treatment of Mucopolysaccharidoses$10,609
F32 · FY2012 · DK · contact PI
Substrate Reduction Therapy Strategies for Treatment of Mucopolysaccharidoses$53,042
F32 · FY2011 · DK · contact PI
Substrate Reduction Therapy Strategies for Treatment of Mucopolysaccharidoses$50,474
F32 · FY2010 · DK · contact PI